ATE237584T1 - Alpha-aminosäureamide, ihre herstellung und ihre therapeutische anwendung - Google Patents

Alpha-aminosäureamide, ihre herstellung und ihre therapeutische anwendung

Info

Publication number
ATE237584T1
ATE237584T1 AT97933680T AT97933680T ATE237584T1 AT E237584 T1 ATE237584 T1 AT E237584T1 AT 97933680 T AT97933680 T AT 97933680T AT 97933680 T AT97933680 T AT 97933680T AT E237584 T1 ATE237584 T1 AT E237584T1
Authority
AT
Austria
Prior art keywords
alpha
production
amino acid
acid amides
therapeutic use
Prior art date
Application number
AT97933680T
Other languages
English (en)
Inventor
Paolo Chiesi
Paolo Ventura
Maurizio Delcanale
Renato De Fanti
Elisabetta Armani
Gino Villetti
Claudio Pietra
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of ATE237584T1 publication Critical patent/ATE237584T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT97933680T 1996-07-23 1997-07-15 Alpha-aminosäureamide, ihre herstellung und ihre therapeutische anwendung ATE237584T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI001544A IT1283489B1 (it) 1996-07-23 1996-07-23 Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
PCT/EP1997/003773 WO1998003472A1 (en) 1996-07-23 1997-07-15 Alpha-amino acid amides, preparation thereof and the therapeutical use thereof

Publications (1)

Publication Number Publication Date
ATE237584T1 true ATE237584T1 (de) 2003-05-15

Family

ID=11374651

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97933680T ATE237584T1 (de) 1996-07-23 1997-07-15 Alpha-aminosäureamide, ihre herstellung und ihre therapeutische anwendung

Country Status (26)

Country Link
US (1) US6114391A (de)
EP (1) EP0951465B1 (de)
JP (1) JP4542208B2 (de)
CN (1) CN1211351C (de)
AR (1) AR007963A1 (de)
AT (1) ATE237584T1 (de)
AU (1) AU729176B2 (de)
CA (1) CA2261259C (de)
CZ (1) CZ295824B6 (de)
DE (1) DE69721052T2 (de)
DK (1) DK0951465T3 (de)
ES (1) ES2195158T3 (de)
HU (1) HU225623B1 (de)
ID (1) ID17999A (de)
IL (1) IL128020A (de)
IT (1) IT1283489B1 (de)
MY (1) MY118244A (de)
NO (1) NO326826B3 (de)
NZ (1) NZ333869A (de)
PT (1) PT951465E (de)
RU (1) RU2174511C2 (de)
SI (1) SI0951465T1 (de)
TR (1) TR199900087T2 (de)
TW (1) TW557291B (de)
WO (1) WO1998003472A1 (de)
ZA (1) ZA976479B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672746A (en) 1994-08-30 1997-09-30 American Biogenetic Sciences, Inc. Antiproliferative and neurotrophic molecules
HUP0102456A3 (en) 1998-06-22 2003-07-28 American Biogenetic Sciences The use of valproic acid analog for the treatment and prevention of migraine and affective illness
US20030035784A1 (en) 2001-03-05 2003-02-20 Kao Corporation Hair cosmetic, aminocarboxylic acid amide and method for producing the same
DE60122541T2 (de) * 2001-12-21 2007-09-13 Chiesi Farmaceutici S.P.A. 2-Indanylaminoderivate zur Therapie von chronischen, akuten oder entzündlichen Schmerzen
FR2843590B1 (fr) * 2002-08-14 2007-10-05 Prestwick Scient Capital Inc Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique
US20040082543A1 (en) * 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
ES2309778T3 (es) * 2004-08-03 2008-12-16 Chiesi Farmaceutici S.P.A. Derivados de acidos 1-fenilalcanocarboxilicos para el tratamiento de enfermedades neurodegenerativas.
US9475757B2 (en) 2013-05-03 2016-10-25 Council Of Scientific & Industrial Research Synthesis of anti-Parkinson agent
CN105646252A (zh) * 2016-02-25 2016-06-08 吉尔生化(上海)有限公司 一种丝氨酸酰胺盐酸盐的合成方法
BR112021026076A2 (pt) * 2019-06-25 2022-03-29 Amtixbio Co Ltd Composto derivado introduzindo o grupo bifenila no novo ácido aminoalcanoico e composição farmacêutica antifúngica compreendendo o mesmo
EP4337316A1 (de) * 2021-05-11 2024-03-20 Awakn Ls Europe Holdings Limited Therapeutische aminoindanverbindungen und zusammensetzungen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010599A1 (de) * 1979-03-22 1980-10-09 Continental Pharma Derivate von glycinamid, deren herstellung und verwendung
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
NL8800260A (nl) * 1988-02-04 1989-09-01 Stamicarbon Alpha-n-hydroxyaminozuren, amiden en andere derivaten daarvan.
DE68928174T2 (de) * 1988-03-16 1997-12-18 Eisai Co., Ltd., Tokio/Tokyo Verfahren zur Herstellung von Cephemderivaten
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5198547A (en) * 1992-03-16 1993-03-30 South Alabama Medical Science Foundation, Usa Process for N5-formylating tetrahydropteridines
GB9306886D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
GB9306899D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
US5332840A (en) * 1993-05-27 1994-07-26 Bristol-Myers Squibb Company Method for preparing a benzaldehyde intermediate
EP0767780B1 (de) * 1994-06-28 1999-12-15 Bayer Ag Aminosäure-derivate und ihre verwendung als schädlingsbekämpfungsmittel

Also Published As

Publication number Publication date
PT951465E (pt) 2003-08-29
ITMI961544A0 (de) 1996-07-23
JP2001506577A (ja) 2001-05-22
IL128020A (en) 2002-04-21
EP0951465A1 (de) 1999-10-27
ID17999A (id) 1998-02-19
DE69721052D1 (de) 2003-05-22
EP0951465B1 (de) 2003-04-16
ES2195158T3 (es) 2003-12-01
SI0951465T1 (en) 2003-08-31
CZ295824B6 (cs) 2005-11-16
US6114391A (en) 2000-09-05
CZ18299A3 (cs) 1999-06-16
NO326826B3 (no) 2010-06-07
TR199900087T2 (xx) 1999-03-22
CA2261259C (en) 2006-10-03
CA2261259A1 (en) 1998-01-29
HU225623B1 (en) 2007-05-02
AU3695297A (en) 1998-02-10
AR007963A1 (es) 1999-11-24
MY118244A (en) 2004-09-30
HUP9902992A3 (en) 2004-04-28
WO1998003472A1 (en) 1998-01-29
IT1283489B1 (it) 1998-04-21
JP4542208B2 (ja) 2010-09-08
AU729176B2 (en) 2001-01-25
RU2174511C2 (ru) 2001-10-10
CN1211351C (zh) 2005-07-20
NO990300D0 (no) 1999-01-22
DE69721052T2 (de) 2004-02-05
NO326826B1 (no) 2009-02-23
ITMI961544A1 (it) 1998-01-23
ZA976479B (en) 1998-03-02
DK0951465T3 (da) 2003-08-11
IL128020A0 (en) 1999-11-30
TW557291B (en) 2003-10-11
NZ333869A (en) 2000-05-26
CN1225625A (zh) 1999-08-11
NO990300L (no) 1999-01-22

Similar Documents

Publication Publication Date Title
DE69529026D1 (de) Trehalose, ihre Herstellung und ihre Verwendung
DE69710612D1 (de) Zeolith des im-5 -typs, dessen herstellung und katalytische verwendungen
ATE260343T1 (de) Bernsteinsäure herstellung und reinigung
ATE432940T1 (de) Substituierte isochinolin-3-carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel
ID23600A (id) Turunan tiazolidin dan oksazolidin, pembuatan dan penggunaannya untuk pengobatan (pecahan dari p-950453)
ATE284392T1 (de) Substituierte 2-phenylbenzimidazole, deren herstellung und anwendung
DE69836514D1 (de) Elektrodenkörper, mit diesem versehener Akkumulator, sowie Herstellung des Elektrodenkörpers und des Akkumulators
DE69814431D1 (de) 3,3-diarylpropylamine , ihre verwendung und herstellung
DE60001451T2 (de) 1,4-diazabicyclo[3.2.2]nonan-4-carboxylat und carboxamidderivate, ihre herstellung und therapeutische verwendung
DE60002526D1 (de) Herstellung von Tricyclodecandicarbaldehyd, Pentacyclopentadecandicarbaldehyd und der entsprechenden Dimethanole
DE59706602D1 (de) 3-Hydroxy-Pyridin-2-carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
DE69901177D1 (de) Platinkomplex, dessen herstellung und dessen therapeutische verwendung
DE69715210D1 (de) Modifiziertes mcm-56, seine herstellung und anwendung
DE60013021D1 (de) Herstellung von S,S und R,S Aminosäuren-Isosteren
FI956298L (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
DE69521595D1 (de) Optisch-aktives Benzothiepin-Derivate, ihre Herstellung und Verwendung
DE69532131D1 (de) Heizvorrichtung und ihre herstellung
DE69526384D1 (de) Wasserabweisende Mittel, deren Herstellung und deren Anwendung
ATE237584T1 (de) Alpha-aminosäureamide, ihre herstellung und ihre therapeutische anwendung
DE69808921D1 (de) 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOL-1-ACETAMID-DERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE ANWENDUNG
DE59711704D1 (de) Neue carbonsäurederivate, ihre herstellung und verwendung
DE69330075D1 (de) Oxazolinderivate, ihre Herstellung und Anwendung
DE69604071D1 (de) Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung
DE69905714D1 (de) Platinkomplex, dessen herstellung und dessen therapeutische anwendung
DE69611303D1 (de) Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0951465

Country of ref document: EP

REN Ceased due to non-payment of the annual fee